|
News Advisory
NIDA Meeting to Look at Drug-Impaired
Decision-Making and HIV Transmission
One of First-Ever NIH Meetings to Examine the
Role between Non-Injection Drug Use and HIV/AIDS
The National Institute on Drug Abuse (NIDA), part of the
National Institutes of Health (NIH), is holding a two day
meeting to explore wide-ranging issues related to drug
abuse, impaired decision making, and HIV/AIDS. Drug
Abuse and Risky Behaviors: The Evolving Dynamics of HIV/AIDS will
provide a broad understanding of the multiple ways that
drug abuse and addiction affect the spread of HIV/AIDS
and how research can inform public health policy. Presentations
will focus on the successes, research challenges, and opportunities
for addressing the evolving HIV/AIDS pandemic. Attendees
will be drawn from the research community, public health
organizations, Federal agencies, and drug abuse and HIV/AIDS
organizations.
Drug abuse and addiction continue to fuel the spread of
HIV/AIDS in the United States and abroad. To address this
significant public health threat, research is examining
every aspect of HIV/AIDS, drug abuse, and addiction, including
risk behaviors associated with both injection and non-injection
drug abuse, how drugs of abuse alter brain function and
impair decision making, and HIV prevention and treatment
strategies for diverse groups.
The meeting is being held in collaboration with the National
Institute on Alcohol Abuse and Alcoholism (NIAAA), the National
Institute of Allergy and Infectious Diseases (NIAID), the
National Institute on Child Health and Human Development
(NICHD), and the National Institute of Mental Health (NIMH).
|
What: |
Drug Abuse and Risky Behaviors: The Evolving
Dynamics of HIV/AIDS. |
When: |
Tuesday, May 8, 2007
8:15 a.m. — 4:30 p.m.
Wednesday, May 9, 2007
8:30 a.m. — 12:15 p.m. |
Where: |
Natcher Conference Center
National Institutes of Health
9000 Rockville Pike
Bethesda, MD 20892 |
Who: |
Featured Speakers
Dr. Nora D. Volkow, Director, NIDA
Dr. Anthony S. Fauci, Director, NIAID |
Info: |
Topics that will be covered include, but are
not limited to, the following:
- How drugs of abuse alter brain function, leading to
impaired decision making and risky behaviors, which in
turn can facilitate the acquisition and transmission
of HIV;
- How and to what extent substance abuse influences
sexual risk behaviors;
- How substance abuse affects HIV/AIDS risk in diverse
populations (e.g., adolescents, minorities, those involved
with the criminal justice system); and
- How testing and counseling can be incorporated as a
key component of HIV prevention strategies for drug-abusing
populations.
|
|
A full agenda and speaker list is available at: http://conferences.masimax.com/riskybehaviors/agenda.cfm
The National Institute on Drug Abuse is a component of the National
Institutes of Health, U.S. Department of Health and Human Services. NIDA
supports most of the world’s research on the health aspects of drug abuse
and addiction. The Institute carries out a large variety of programs
to ensure the rapid dissemination of research information and its implementation
in policy and practice. Fact sheets on the health effects of drugs of
abuse and information on NIDA research and other activities can be found
on the NIDA home page at www.drugabuse.gov.
The National Institutes of Health (NIH) — The Nation's Medical
Research Agency — includes 27 Institutes and Centers and
is a component of the U.S. Department of Health and Human Services.
It is the primary federal agency for conducting and supporting basic,
clinical and translational medical research, and it investigates the
causes, treatments, and cures for both common and rare diseases. For
more information about NIH and its programs, visit www.nih.gov.
|